Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions such as MS.

Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

A study of 125 children with POMS and 145 without major health disorders found that epigenetic age tended to be higher in children with POMS.

Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.

If a routine streamlined a process and passed the common sense test, I was more than happy to adopt it. However, if it caused more harm than good, I took great pride in being able to adapt quickly. In ...

Infections and stressful life events in childhood may increase the risk of developing MS, according to a study.

Four Canadian nurses are among the 11 recipients of this year's International Nightingale Awards, which support innovative ...

Body mass index (BMI) does not seem to affect responses to stem cell transplant in people with MS, a study found.

Ocrevus appears to be a safe and effective treatment for children and adolescents with MS, according to real-world data from ...

MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...

Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.